Posted by David T. Drummond ⎜ Jan 20, 2015 ⎜ Company
Using equipment supplied by isoSolutions, researchers at four Canadian facilities announced success in the production of Technetium-99m, the workhorse of nuclear medicine, in medical cyclotrons. An interdisciplinary team made up of researchers from TRIUMF, the BC Cancer Agency, the Centre for Probe Development and Commercialization, and Lawson Health Research Institute announced their findings at triumf.ca.
These four research institutions are customers of isoSolutions and the development of this production process was performed on Trasis Mini-All-in-One Automated Synthesis Modules. The Mini-AIO is an automated instrument dedicated to the labeling of tracers with short life-time radioactive isotopes used in diagnostics and therapeutics. It addresses the needs of pharmaceutical production centers as well as of hospitals and research centers. Trasis All-in-One modules are distributed in Canada and Latin America by isoSolutions.
David Drummond, Managing Director of isoSolutions, stated: “We congratulate our customers for this exciting success and we are pleased that one of our products played a role in the project.”
About isoSolutions Marketing & Management Inc.
More information on the company can be found at isoSolutions.